Lamar B. Mercer
Chief Executive Officer, Clinical stage oncology biotechnology
San Diego, CA · (406) 555 0105 · name@example.com · linkedin.com/in/lamarbmercer
Key Qualifications
EXPERIENCE
Twenty six years in biopharmaceutical leadership, seven as chief executive officer
INDUSTRIES
Clinical stage oncology biotechnology, commercial stage specialty pharmaceuticals, venture backed startups
SPECIALTIES
Development strategy, regulatory milestones, financing and partnering, organizational scale up
SYSTEMS
Veeva Vault, Medidata Rave, Oracle NetSuite, Workday, Tableau
CREDENTIALS
Doctor of Philosophy in pharmacology; board director of two life science companies
EDUCATION
Doctor of Philosophy in pharmacology, Master of Business Administration
Executive Summary
Chief executive officer of a clinical stage oncology company with 180 employees and two programs in phase two. Twenty six years in the industry across research, development and general management, with two new drug application approvals to his name and a track record of financing programs through to data readouts.
Signature Achievements
- Closed three financing rounds totaling 340 million dollars, each one funding the company past a defined clinical data readout.
- Took the lead program from investigational new drug submission to phase two proof of concept data in thirty three months.
- Signed a regional development and commercialization agreement worth 55 million dollars up front and 420 million dollars in milestone payments.
- Grew the company from 46 employees to 180 across research, development and general and administrative functions.
- Delivered two Food and Drug Administration approvals earlier in his career as head of development at a specialty company.
- Held cash runway above eighteen months in every quarter of the last five years.
Professional Experience
Chief Executive Officer
Torrey Cliffs Therapeutics, San Diego, CA 2019 to present
Clinical stage oncology company with two phase two programs, three discovery programs, 180 employees and an annual operating budget of 165 million dollars
- Leads a six person executive team and reports to a board of eight including three investor directors.
- Sets the corporate strategy, the portfolio priorities and the financing plan the board approves each year.
- Owns investor relations, including quarterly reporting, annual guidance and scientific update presentations.
- Negotiated the regional partnership and chairs the joint steering committee that governs it.
- Holds final accountability for regulatory commitments, clinical quality and the company compliance program.
President and Chief Operating Officer
Pacific Bluff Pharmaceuticals, Carlsbad, CA 2013 to 2019
Commercial stage specialty company with three marketed products and revenue of 290 million dollars
- Ran development, manufacturing and commercial operations for the marketed portfolio.
- Led the launch of a specialty product that reached 118 million dollars of annual revenue in year three.
- Rebuilt the supply chain after a contract manufacturer failure with no interruption to patient supply.
- Reduced operating expense as a share of revenue from fifty one percent to thirty nine percent over four years.
Senior Vice President of Development
Coronado Bay Biosciences, San Diego, CA 2004 to 2013
Development stage company advancing three oncology and supportive care assets
- Led clinical development, regulatory affairs and program management across the portfolio.
- Delivered two new drug application approvals as the development leader.
- Built the regulatory function that carried the company through four agency meetings and two filings.
- Recruited the executive team that carried both filings through review and approval.
Licensure and Certification
Board director, two privately held life science companies
Member, Biotechnology Innovation Organization
Member, American Association for Cancer Research
Education
Master of Business Administration, University of California San Diego, 2011
Doctor of Philosophy in pharmacology, University of Washington, 2000
Bachelor of Science in biology, Louisiana State University, 1994
Core Skills
Corporate strategy · Clinical portfolio prioritization · Financing and investor relations · Partnering and alliance governance · Regulatory milestone delivery · Executive team leadership · Board reporting · Organizational scale up · Operating budget ownership · Compliance oversight